Form4insider filings, from the source

SEC Form 4 · accession 0001127602-18-013142

PDS Biotechnology Corp · PDSB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Kurt G Conti
Director
Period of report
Mar 23, 2018
Accepted (ET)
Mar 30, 2018 · 7:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001472091

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2,F3,F4Mar 23, 2018J58,476$0.00D0IBy Trust
Common Stockholding———324,541D
Common StockF5holding———789,420IBy Oakwood Capital, Llc

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses